• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

FDA decision on preterm birth drug’s withdrawal nears, putting spotlight on patients, agency

cafead

Administrator
Staff member
  • cafead   Mar 06, 2023 at 11:52: PM
via The hormonal shot Makena is the only treatment available to lower the risk of early labor. But the FDA has sought its withdrawal since a 2019 study showed it didn’t work.

article source
 

<